Research Focus

Former Employee. Research Facilities; Research Technician, Sr

Recent additions – View all

1. Janus kinase inhibition by ruxolitinib extends dasatinib- and dexamethasone-induced remissions in a mouse model of Ph+ ALL

   Journal Article

   Appelmann, I.; Rillahan, C. D.; de Stanchina, E.; Carbonetti, G.; Chen, C.; Lowe, S. W.; Sherr, C. J.
   Blood (2015)

   Fulltext@MSK | Save
2. Prevention of minimal residual disease in Ph plus ALL

   Meeting Abstract

   Appelmann, I.; Rillahan, C. D.; de Stanchina, E.; Carbonetti, G.; Chen, C.; Lowe, S. W.; Sherr, C. J.
   Oncology Research and Treatment (2014)

   Fulltext@MSK | Save
3. Prevention of minimal residual disease in Ph+ ALL

   Meeting Abstract

   Appelmann, I.; DeStanchina, E.; Carbonetti, G.; Chen, C.; Lowe, S. W.; Sherr, C. J.
   Blood (2013)

   Fulltext@MSK | Save